Cargando…
Clinical heterogeneity in monogenic chylomicronaemia
Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogen...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693862/ https://www.ncbi.nlm.nih.gov/pubmed/36423940 http://dx.doi.org/10.1136/bcr-2022-251411 |
_version_ | 1784837651375849472 |
---|---|
author | Heidemann, Britt E Bemelmans, Remy H H Marais, A David Visseren, Frank L J Koopal, Charlotte |
author_facet | Heidemann, Britt E Bemelmans, Remy H H Marais, A David Visseren, Frank L J Koopal, Charlotte |
author_sort | Heidemann, Britt E |
collection | PubMed |
description | Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up. |
format | Online Article Text |
id | pubmed-9693862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-96938622022-11-26 Clinical heterogeneity in monogenic chylomicronaemia Heidemann, Britt E Bemelmans, Remy H H Marais, A David Visseren, Frank L J Koopal, Charlotte BMJ Case Rep Case Reports: Rare disease Chylomicronaemia accompanies hypertriglyceridaemia, usually due to a polygenic predisposition in combination with secondary risk factors. Monogenic chylomicronaemia represents a small subgroup of patients with hypertriglyceridaemia. This article describes three patients and illustrates the heterogeneity in the presentation of monogenic chylomicronaemia. The first case is a man with mild hypertriglyceridaemia who is a compound heterozygote for two variants in the LMF1 gene, without relevant medical history. The second case is a woman who is a double heterozygote of variants in the LPL and APOA5 genes. She experienced pancreatitis. The third case is a man, with recurrent pancreatitis attributed to severe hypertriglyceridaemia and homozygous for a variant in the APOC2 gene. This article highlights that in patients with hypertriglyceridaemia, the absence of pancreatitis or the presence of mild hypertriglyceridaemia does not exclude monogenic chylomicronaemia. Genetic screening should be considered in patients with unexplained or severe hypertriglyceridaemia, to determine appropriate treatment and follow-up. BMJ Publishing Group 2022-11-23 /pmc/articles/PMC9693862/ /pubmed/36423940 http://dx.doi.org/10.1136/bcr-2022-251411 Text en © BMJ Publishing Group Limited 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Case Reports: Rare disease Heidemann, Britt E Bemelmans, Remy H H Marais, A David Visseren, Frank L J Koopal, Charlotte Clinical heterogeneity in monogenic chylomicronaemia |
title | Clinical heterogeneity in monogenic chylomicronaemia |
title_full | Clinical heterogeneity in monogenic chylomicronaemia |
title_fullStr | Clinical heterogeneity in monogenic chylomicronaemia |
title_full_unstemmed | Clinical heterogeneity in monogenic chylomicronaemia |
title_short | Clinical heterogeneity in monogenic chylomicronaemia |
title_sort | clinical heterogeneity in monogenic chylomicronaemia |
topic | Case Reports: Rare disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693862/ https://www.ncbi.nlm.nih.gov/pubmed/36423940 http://dx.doi.org/10.1136/bcr-2022-251411 |
work_keys_str_mv | AT heidemannbritte clinicalheterogeneityinmonogenicchylomicronaemia AT bemelmansremyhh clinicalheterogeneityinmonogenicchylomicronaemia AT maraisadavid clinicalheterogeneityinmonogenicchylomicronaemia AT visserenfranklj clinicalheterogeneityinmonogenicchylomicronaemia AT koopalcharlotte clinicalheterogeneityinmonogenicchylomicronaemia |